Table 4 In silico validation of TACSTD2 methylation results using TCGA KIRC data
Locus | Position on chromosome 1 | 1Clinicopathology | 2survival data | ||||||
|---|---|---|---|---|---|---|---|---|---|
Metastasis | Tumor stage | Differentiation | |||||||
p | OR | p | OR | p | OR | p | HR | ||
cg21536783 | 59,041,407 | 3.10*10−03 | 65.32 | 2.40*10−01 | 2.58 | 6.11*10−01 | 1.50 | 2.97*10−02 | 1.88 |
cg00667789 | 59,042,065 | 3.91*10−05 | 44.44 | 8.56*10−05 | 14.03 | 1.34*10−05 | 18.92 | 2.97*10−04 | 2.50 |
cg00554413 | 59,042,113 | 2.14*10−04 | 104.97 | 3.34*10−03 | 14.66 | 1.32*10− 03 | 18.75 | 3.27*10− 02 | 1.56 |
cg24851854 | 59,042,275 | 5.51*10−07 | 68.88 | 3.67*10−08 | 39.14 | 3.39*10−08 | 47.07 | 4.95*10−06 | 2.83 |
cg05065507 | 59,042,931 | 1.11*10− 06 | 65.79 | 2.03*10−05 | 31.81 | 6.40*10−04 | 19.86 | 7.70*10− 06 | 2.66 |
cg10347335 | 59,042,971 | 4.47*10− 07 | 359.26 | 2.05*10−05 | 74.78 | 8.85*10−04 | 32.63 | 1.54*10−03 | 1.98 |
cg13443627 | 59,043,070 | 8.56*10−07 | 95.42 | 2.77*10−06 | 28.12 | 1.07*10−05 | 23.73 | 4.99*10−04 | 2.05 |
cg17210938 | 59,043,173 | 2.82*10−05 | 116.62 | 1.05*10−05 | 65.44 | 1.11*10−03 | 21.10 | 1.80*10−05 | 2.54 |
cg16080552 | 59,043,199 | 5.62*10−06 | 47.95 | 3.98*10−05 | 17.08 | 1.18*10−04 | 15.43 | 4.76*10−07 | 2.88 |
cg04863005 | 59,043,208 | 5.34*10−06 | 36.00 | 1.39*10−05 | 14.05 | 2.96*10−04 | 8.81 | 1.34*10−05 | 2.66 |
cg16699148 | 59,043,255 | 2.53*10−04 | 54.55 | 3.32*10−03 | 13.26 | 1.47*10−02 | 8.66 | 6.59*10−03 | 1.76 |
cg01821018 | 59,043,280 | 3.04*10−04 | 180.71 | 1.03*10−02 | 13.66 | 1.12*10−02 | 12.72 | 7.23*410−02 | 1.48 |
cg19813884 | 59,043,370 | 8.42*10−06 | 2179.41 | 2.3*10−03 | 80.46 | 3.10*10−02 | 23.44 | 1.61*10−03 | 1.93 |
cg05346878 | 59,043,576 | 8.10*10−04 | 16.72 | 5.51*10−01 | 1.48 | 3.58*10−01 | 1.83 | 2.82*10−02 | 1.93 |
cg27398499 | 59,043,873 | 1.13*10−04 | 27.96 | 7.97*10−01 | 1.19 | 4.06*10−01 | 1.76 | 1.19*10−01 | 1.46 |